New York State Common Retirement Fund decreased its holdings in shares of Exponent, Inc. (NASDAQ:EXPO – Free Report) by 11.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 28,629 shares of the business services provider’s stock after selling 3,561 shares during the quarter. New York State Common Retirement Fund owned about 0.06% of Exponent worth $2,520,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also made changes to their positions in the company. Operose Advisors LLC bought a new position in shares of Exponent during the third quarter valued at approximately $39,000. Signaturefd LLC raised its holdings in shares of Exponent by 157.7% in the third quarter. Signaturefd LLC now owns 915 shares of the business services provider’s stock valued at $78,000 after acquiring an additional 560 shares in the last quarter. Covestor Ltd lifted its position in shares of Exponent by 24.8% in the 3rd quarter. Covestor Ltd now owns 1,474 shares of the business services provider’s stock worth $126,000 after purchasing an additional 293 shares during the period. Parkside Financial Bank & Trust boosted its stake in shares of Exponent by 10.5% during the third quarter. Parkside Financial Bank & Trust now owns 1,468 shares of the business services provider’s stock valued at $126,000 after purchasing an additional 140 shares in the last quarter. Finally, Quadrature Capital Ltd increased its holdings in Exponent by 6.7% during the third quarter. Quadrature Capital Ltd now owns 2,452 shares of the business services provider’s stock valued at $210,000 after buying an additional 155 shares during the period. 92.37% of the stock is owned by hedge funds and other institutional investors.
Exponent Trading Up 0.2 %
NASDAQ EXPO opened at $94.68 on Wednesday. The firm’s fifty day simple moving average is $82.08 and its two-hundred day simple moving average is $82.07. The firm has a market capitalization of $4.79 billion, a P/E ratio of 47.82 and a beta of 0.64. Exponent, Inc. has a 12-month low of $64.61 and a 12-month high of $102.72.
Exponent Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 21st. Stockholders of record on Friday, June 7th will be issued a $0.28 dividend. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.18%. The ex-dividend date of this dividend is Friday, June 7th. Exponent’s dividend payout ratio is presently 56.57%.
Analyst Upgrades and Downgrades
EXPO has been the topic of several recent research reports. Truist Financial increased their target price on Exponent from $95.00 to $100.00 and gave the company a “buy” rating in a research report on Monday, April 29th. StockNews.com upgraded Exponent from a “sell” rating to a “hold” rating in a research note on Monday, March 4th.
View Our Latest Stock Report on Exponent
Insiders Place Their Bets
In other news, VP Bradley A. James sold 3,528 shares of the company’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $95.00, for a total value of $335,160.00. Following the sale, the vice president now directly owns 2,030 shares of the company’s stock, valued at approximately $192,850. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Exponent news, VP Bradley A. James sold 3,528 shares of the company’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $95.00, for a total value of $335,160.00. Following the sale, the vice president now directly owns 2,030 shares of the company’s stock, valued at $192,850. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Eric Guyer sold 1,650 shares of the stock in a transaction dated Tuesday, April 30th. The stock was sold at an average price of $92.58, for a total value of $152,757.00. Following the sale, the insider now directly owns 1,846 shares in the company, valued at $170,902.68. The disclosure for this sale can be found here. In the last ninety days, insiders sold 8,558 shares of company stock valued at $753,402. 2.20% of the stock is owned by insiders.
Exponent Company Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Read More
- Five stocks we like better than Exponent
- Find and Profitably Trade Stocks at 52-Week Lows
- Garmin Navigates to New Highs Driven By Wearables Trend
- How to Invest in Biotech Stocks
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- The 3 Best Retail Stocks to Shop for in August
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.